Why symptom relief matters
A more comfortable walk or less difficulty with everyday movement can be a meaningful improvement for someone living with knee osteoarthritis. Arthrosamid is intended to help manage those symptoms. A treatment does not have to rebuild cartilage to offer something useful.
What the cohort actually measured
Professor Lee’s co-authored 24-month study tracked pain, Oxford Knee Score and Lysholm function scores. Those measures help describe how people feel and function. The authors identify the lack of structural imaging analysis as a limitation.
The findings can inform a discussion about symptom improvement. They do not demonstrate that Arthrosamid regrows cartilage or restores the original joint surface.
What about the published MRI changes?
The 2022 case report by Maulana, Cole and Lee describes reduced patellofemoral bone marrow lesions at four months, alongside improved symptoms in one patient. Bone marrow lesions are findings within the bone beneath the joint surface; they are not the same as a measurement of newly grown cartilage.
This is an interesting clinical observation and a reason for further study. It should be described for what it shows, without turning one patient’s MRI change into a general regeneration claim.
Keep caring for the whole joint
Discuss how your diagnosis, alignment, stability and usual activities fit into the long-term plan. Feeling better can be a welcome part of that plan, while follow-up helps you decide how to progress.
Pain relief does not mean that joint damage will inevitably continue, either. Review new symptoms and changing goals with the clinician rather than assuming that less pain means either a cure or hidden harm.
Ask what success means for you
A useful follow-up conversation covers what has changed, which activities are easier and whether other concerns remain. If your priority is structural cartilage repair, ask which options address that goal and what evidence supports them for your knee.
Sources and further reading
- Gao et al. (2025): 24-month prospective knee cohort
- Published correction: ethics approval reference
- Maulana, Cole & Lee (2022): patellofemoral MRI case report
- Arthrosamid instructions for use, October 2025
General information to support a clinical conversation. AMSK and Professor Lee are part of the MSK Doctors group; group publications are identified above.
